Andrea B Apolo, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea B Apolo, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06228066 · Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)National Cancer Institute (NCI) · recruiting · Small Cell Carcinoma of the Bladder, High Grade Neuroendocrine Tumors of the Urinary Tract · principal investigator
- Ph2NCT06161532 · Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...National Cancer Institute (NCI) · recruiting · Small Cell Carcinoma of the Bladder, Small Cell Carcinoma of the Urinary Tract, Squamous Cell Carcinoma of the Bladder · principal investigator
- Ph2NCT06041503 · Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)National Cancer Institute (NCI) · recruiting · Adenocarcinoma of the Bladder, Squamous Cell Carcinoma of the Bladder, Testicular Germ Cell Tumors · principal investigator
- N/ANCT04923178 · A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract MalignanciesNational Cancer Institute (NCI) · recruiting · Urothelial Cancer, Bladder Cancer, Genitourinary Cancer · principal investigator
- Ph2NCT04501094 · A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial CarcinomaNational Cancer Institute (NCI) · terminated · Urothelial Cancer · principal investigator
- Ph1NCT04235777 · Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary MalignanciesNational Cancer Institute (NCI) · active not recruiting · Urothelial Cancer, Bladder Cancer, Genitourinary Cancer · principal investigator
- N/ANCT03327883 · Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder CancerNational Cancer Institute (NCI) · completed · Bladder Cancer · principal investigator
- Ph2NCT02788201 · Genomic Based Assignment of Therapy in Advanced Urothelial CarcinomaNational Cancer Institute (NCI) · completed · Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms · principal investigator
- Ph2NCT01967576 · Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/ParagangliomaNational Cancer Institute (NCI) · completed · Pheochromocytoma, Paraganglioma · principal investigator
- Ph2NCT01688999 · Cabozantinib for Advanced Urothelial CancerNational Cancer Institute (NCI) · completed · Urothelial Carcinoma, Urethral Neoplasms, Urinary Bladder Neoplasms · principal investigator
- Ph1NCT01352962 · Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsNational Cancer Institute (NCI) · completed · Urethral Neoplasms, Neoplasms, Urethral, Cancer of the Urethra · principal investigator
- Ph2NCT01328574 · TRC105 in Adults With Advanced/Metastatic Urothelial CarcinomaNational Cancer Institute (NCI) · completed · Urothelial Carcinoma, Ureteral Neoplasms, Ureter Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.